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We studied the persistence of porcine reproductive and respiratory syndrome virus (PRRSV) in individual
experimentally infected pigs, during a period of up to 150 days postinfection (dpi). The results of this study
suggest that the persistence of PRRSV involves continuous viral replication but that it is not a true steady-state
persistent infection. The virus eventually clears the body and seems to do it in most of the animals by 150 dpi
or shortly thereafter. High genetic stability was seen for several regions of the persistent PRRSV’s genome,
although some consistent mutations in the genes of envelope glycoproteins and M protein were also observed.
Previous reports indicate that porcine reproductive and respiratory syndrome virus (PRRSV) can persist in pigs for long
periods of time after initial infection and that persistently infected animals can shed infectious virus (4, 5, 17, 19). The
mechanisms by which or the condition in which PRRSV persists in the animal host is not known. Few studies of the occurrence of in vivo persistence of PRRSV have been reported
(4, 14). Likewise, the genetic stability of PRRSV during persistence is unknown. The genetic stability of ORF7 (the gene
coding for the PRRSV nucleocapsid) has been studied during
serial in vivo passages (10). Likewise, a segment of 537 nucleotides comprising the carboxyl-terminal end of ORF4 and the
amino-terminal end of ORF5 has been studied in individual
persistently infected animals (14). While the ORF7 sequence
was reported to be highly stable during persistence in a group
of animals (9, 10), the ectodomain of ORF5 has shown mutations that were suggested to be associated with persistence in
individual hosts (14).
We experimentally infected pigs with the pathogenic PRRSV
isolate 16244B (2) to study the extent of PRRSV gene expression during persistence in the natural host. We also determined the genetic stability of the persistent isolates (those
recovered sequentially from an individual animal) by analyzing
some selected areas of the genome. The genomic areas studied
included those probably important for polymerase recognition,
replication initiation, and subgenomic RNA synthesis; the coding sequence for the structural and NSP1a proteins; and the 5⬘
and 3⬘ noncoding regions (NCRs).
Ten pigs (1 to 2 months old) from an unvaccinated PRRSVfree herd were inoculated intranasally with 106.0 50% cell
culture infectious doses of PRRSV strain 16244B per ml,
delivered in volumes of 0.5 ml/nostril. Three uninfected pigs,
matching the infected group in age, breed, and farm of origin,
were used as controls. Different isolation rooms (biosafety
level 2) were used to separate control animals from those
* Corresponding author. Mailing address: Department of Veterinary and Biomedical Sciences, University of Nebraska—Lincoln, Lincoln, NE 68583-0905. Phone: (402) 472-7809. Fax: (402) 472-3094.
E-mail: fosorio@unl.edu.
† This paper is published with the authorization of the Director of
the Agricultural Research Division of the University of Nebraska—
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infected with PRRSV during the 5-month period of the experiment. Animals were clinically inspected on a daily basis. Serum and tonsil biopsy samples were taken at different times
postinfection (p.i.), ranging from 7 to 150 days p.i. (dpi), and
used for (i) assessment of PRRSV antibody response, (ii) infectious virus isolation, and (iii) PRRSV RNA detection by
reverse transcription-PCR (RT-PCR). At 150 dpi, the experiment was terminated and all of the animals were euthanatized
by electrocution, exsanguinated, and necropsied. Samples from
serum, lung, bronchial lymph nodes, and tonsils were collected
and snap-frozen for further PRRSV isolation and viral RNA
detection. Samples were assayed for infectious virus on monolayers of porcine alveolar macrophages (PAMs) and MARC145 cells (8) or by conducting bioassay experiments (see below). The maintenance medium used for PAMs was RPMI
1640 (Sigma) supplemented with 10% fetal calf serum and
gentamicin (50 g/ml). The growth medium used for the
MARC-145 cell line was Eagle’s minimal essential medium
(MEM) supplemented with 10% fetal calf serum and gentamicin (50 g/ml). Virus was isolated from tissue and serum
samples by inoculating six-well plates containing monolayers of
PAMs maintained at 37°C. If no cytopathic effect was observed
in the first passage in PAMs, supernatants were used as inoculum for passages in MARC-145 cells. A total of two additional passages in MARC-145 cells were done before scoring
the sample as negative for infectious PRRSV. The identity of
viral isolates was confirmed by immunofluorescence with the
monoclonal antibody SDOW-17 specific for the PRRSV nucleocapsid protein (13) and identified with the identification
(ID) number of the animal from which the sample inoculum
was originated plus the date (time p.i.) when the sample was
collected. All inoculated pigs developed viremia by day 7 p.i. as
indicated by the recovery of infectious PRRSV from serum
samples in MARC-145 cells (Table 1). Seroconversion, determined by a commercial enzyme-linked immunosorbent assay
(ELISA) (Idexx Laboratories, Portland, Maine), took place
between 7 and 14 dpi, after which ELISA antibodies peaked at
28 to 56 dpi (as assessed by the commercial ELISA’s sampleto-positive ratios). The antibody titers remained on a plateau
after peaking and then declined but remained always above the
positive threshold for the rest of the observation period (data
not shown).
The frequency of recovery of infectious virus by cell culture
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TABLE 1. PRRSV isolation in cell culture or in bioassay
experiments from pigs experimentally infected
with the 16244B isolatea
Result for assay at dpi:
Animal
ID no.

3
4
9
14
17
22
23
27
31
32

7 (cc)

56 (cc)

⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹

84

150

cc

ba

cc

ba

⫹
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺

⫹
⫺
⫺
⫺
⫺
⫹
⫺
⫹
⫹
⫹

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺

⫹
ND
ND
ND
ND
⫺
ND
⫺
⫹
⫺

a
Viruses were isolated in cell culture (cc) (PAMs or MARC-145 cells) or in
bioassays (ba). Day 7 samples were serum samples and were assayed only on
MARC-145 cells. Day 56 and day 84 samples were tonsil biopsy and serum
samples. Day 150 was the time of necropsy (tonsil, bronchial lymph node, lung,
and serum samples). ⫹, positive; ⫺, negative; ND, not done.

assays (PAMs or MARC-145 cells) decreased with time, and
PRRSV was recovered only occasionally up to 84 dpi (Table
1). In addition to cell cultures, experimental inoculation of
susceptible swine (bioassay experiment) was performed with
samples taken at 84 and 150 dpi. We inoculated 1- to 2-weekold piglets, obtained from an unvaccinated PRRSV-free herd,
to assay for the presence of infectious PRRSV in tissue collected from the pigs at long-term-p.i. periods. Tonsil biopsy
samples collected at 84 dpi from each infected animal were
ground separately and mixed with a serum sample collected at
the same time p.i. from the same animal. Each homogenate
typically consisted of 50 to 80 mg of ground tonsil tissue and 2
ml of serum. Approximately 0.5 ml from each homogenate was
stored at ⫺80°C for viral isolation assay in cell cultures. The
remaining 1.5 ml of homogenate was diluted to a volume of 8
ml with MEM, supplemented with gentamicin (50 g/ml), and
used to inoculate the piglets. Tissue samples taken at necropsy
(150 dpi) from the infected animals were ground separately.
Pools of ground tissue from each individual pig were mixed
with serum collected at the same p.i. time point from the same
animal. Typically, each homogenate consisted of 5 to 10 g each
of ground lung, lung lymph node, and tonsil tissues and 4 ml of
serum. MEM supplemented with gentamicin (100 g/ml) was
added in a volume of 15 ml. The suspension was then frozen
and thawed and clarified by low-speed centrifugation. Supernatants were then transferred to new sterile tubes and diluted
1:5 in MEM containing 100 g of gentamicin per ml. A volume
of 12 ml from each sample suspension was used to inoculate
the piglets. Bioassay experimental piglets were inoculated with
1 ml of the supernatants from tissue suspension delivered in
each nostril with the remaining 10 ml of inoculum being delivered intraperitoneally. Each inoculated animal remained individually isolated during the bioassay experiments for a period
of 3 weeks. The progress of the experimental inoculation was
monitored by daily clinical observation and weekly serum sampling which was used for the assessment of viremia and
PRRSV antibody response by ELISA. The isolates obtained
through this bioassay were identified with the ID number of
the animal from which the sample inoculum originated and the
corresponding date of collection, followed by the letter “b.” At
84 dpi, we used 10 piglets for the bioassay experiment (one for
each principal animal). For the sake of economy, at 150 dpi we
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assessed only the samples from those animals that had yielded
positive results at 84 dpi.
PRRSV was isolated in cell cultures from a tonsil biopsy
sample of pig 32 at 56 dpi and from a homogenate of tonsil and
serum samples from pig 3 at 84 dpi. Interestingly, 5 out of 10
animals were persistently infected at 84 dpi, and from those,
two animals remained persistently infected up to 150 dpi, as
indicated by the development of viremia and seroconversion in
the bioassay piglets (Table 1). We did not quantitate the infectious virus per gram of sample. However, the difficulty in
isolating infectious PRRSV by conventional methods and the
strict requirement of bioassay inoculation in order to demonstrate PRRSV infectivity in later stages of the observation
period (approximately 3 to 5 months p.i.) would suggest that
the amount of infectious virus was decreasing progressively
throughout the experiment.
To study the occurrence of viral gene expression, a strandspecific RT was performed to reverse transcribe the negative
form of the viral RNA that occurs during replication, using the
primer 5⬘-GACTGCTTTACGGTCTCTC-3⬘ (11), which anneals to the replicative (minus) RNA form at the 3⬘ end of the
leader. PCR and seminested PCR, with 35 cycles of amplification each, were carried out on the strand-specific RT products. For the PCR, the following oligonucleotides were used:
5⬘-TGCCGCACGGTTTCATCCGATTG-3⬘ (forward primer,
nucleotide [nt] 14728 to 14750), outer reverse primer 5⬘-GGT
GATGCTGTGACGCGGATCAG-3⬘ (nt 15228 to 15250), and
inner reverse primer 5⬘-GCAAGTCCCAGCGCCTTGATT-3⬘
(nt 15138 to 15158). The end product of the seminested PCR
was 430 nt long corresponding to the last 170 nt from ORF6
and the first 270 nt of ORF7. A PCR for the constitutive
␤-actin gene of swine was performed on the tissue samples
collected at necropsy as control for the RNA extraction and
RT reactions using previously published primers (16). All RT
reactions were performed using SuperScript II reverse transcriptase (Gibco BRL) following the manufacturer’s instructions. The PRRSV-negative RNA form was detected at 28 dpi
in tonsil samples from 8 out of 10 infected animals (Table 2),
thus suggesting the occurrence of active viral gene expression
in the tissues under study. There was a significant decrease in
the number of positive animals by day 119 p.i. compared to the
more acute-phase samples at 28 dpi. Only pig 31 showed evi-

TABLE 2. PRRSV-negative strand-specific RT-PCR amplification
in tissue samples of pigs experimentally infected
with PRRSV isolate 16244Ba
Result for dpi:

Animal
ID no.

28

119

150

3
4
9
14
17
22
23
27
31
32
43
47
50

⫺
⫹
⫹
⫹
⫺
⫹
⫹
⫹
⫹
⫹
⫺
⫺
⫺

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫹
⫺
⫺
⫺
⫺

⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺
⫺

a
Animals 43, 47, and 50 are uninfected controls. RT-PCR was performed on
RNA from tonsil samples (days 28 and 119) and from tonsil, lung, lymph node,
and serum samples (day 150). ⫹, positive; ⫺, negative.
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TABLE 3. Predicted amino acid substitutions in Nsp1␣ and ORF2 to ORF7 from persistent PRRSV isolates
recovered from pigs infected with PRRSV strain 16244B

Genome
region

Amino acid substitution from PRRSV isolate:
3-7

3-84

3-84b

3-150b

22-7

22-84b

27-7

27-84b

31-7

31-84b

31-150b

32-7

32-84b

Nsp1␣

A114T

A114T

I81V

A114T

ORF2

Q189R
A223T

Q189R
A223T

Q189R
L203P

Q189R
A223T

ORF3

I215T

I215T

I215T
T64A

S15N

S15N

H79Y
S106G
Q151R

I215T

S15N

ORF4

E35K

E35K

E35K
M157T

A45V

A45V

S51G
F118L

E35K
V127E

A45V

ORF5

N58D
Y141H

N58D

N58D
Y141H

D61N

D61N

D61N

N58D
Y141H

D61N

ORF6

K70E

T63M

K70E

K70E

ORF7

dence of persistent PRRSV gene expression by minus-strandspecific RT-PCR in the tonsil tissue (Table 2). We were unable
to detect the negative form of PRRSV RNA at 150 dpi (Table
2). However, using random hexamers in the RT reaction,
PRRSV total RNA was still detected in tonsil tissue from one
of the persistently infected pigs (animal 31 [data not shown])
for which virological evidence of persistent PRRSV was provided in the bioassay experiment also (Table 1). The low level
of detection of PRRSV RNA (minus) during the late-p.i. period could be a reflection of the lower frequency of this template in the replicative process, which made it undetectable in
most of the animals by the technique we used.
Evidence for persistence of PRRSV infection in individual
animals has been reported previously (5, 17, 19). In this report,
we provide evidence that the virus persists in a replicating,
infectious state in a continuously decreasing percentage of the
convalescent animals. Together, the data from viral isolation
and negative RNA RT-PCR indicate that PRRSV persists
through a “smoldering” type of infection in which the virus
replicates at low levels over time.
To measure the genetic stability of the PRRSV during persistence, we analyzed sequences from viruses recovered at 7
dpi (samples 3-7, 22-7, 27-7, 31-7, and 32-7), at 84 dpi (samples
3-84, 3-84b, 22-84b, 27-84b, 31-84b, and 32-84b), and at 150 dpi
(samples 3-150b and 31-150b). Random hexamers were used to
reverse-transcribe total RNA extracted from monolayers of
MARC-145 cells infected with the above-mentioned PRRSV
isolates recovered during the experiment. The resulting cDNA
was used as a template in the PCR to amplify segments of the
PRRSV genome from nt 25 at the 5⬘ NCR to nt 675 in ORF1a,
the complete sequence of ORF2 to ORF7, and the 3⬘ NCR (all
of them based on our published sequence of PRRSV 16244B
[GenBank accession no. AF046869]). RT-PCR products and
cloned cDNA inserts were sequenced by the dideoxynucleotide
chain-termination method (15). Sequencing reactions were
prepared with the BigDye Terminator Cycle Sequencing kit
(Perkin-Elmer). Sequences were determined with an ABI
PRISM 377 automated DNA sequencer and an ABI PRISM
3700 DNA analyzer. The ABI sequence software version 3.3
was used for lane tracking and trace extraction. Further cDNA
sequencing, genome assembling, and computer analysis were

done as previously described (2). A total of 4.2 kb was sequenced and analyzed for each virus isolate. The PRRSV 5⬘
NCR and the 3⬘ NCR were extremely stable during long-term
persistence, suggesting that virus persistence is not a consequence of mutations in regions most likely involved in polymerase recognition or transcription initiation. The frequency
of nucleotide substitutions at 7 dpi varied from 0 to 0.6/1,000
nt. By day 84 p.i., the frequency of nucleotide substitutions
rose, ranging from 2.1 to 5/1,000 nt (data not shown), which is
similar to that observed for the S gene of the coronavirus
mouse hepatitis virus (1). At day 150 of persistence, the frequency of nucleotide substitutions varied between 3.8 and 3.6
in the two samples analyzed (3-150b and 31-150b) (data not
shown), which is still similar to that reported elsewhere for the
persistence models of the coronavirus mouse hepatitis virus
(1). An observed feature of the nucleotide substitutions during
persistence was that the mutations were almost entirely transitions. The observed bias in PRRSV persistence was higher
than that reported for other virus models (1, 18) and may very
well be a consequence of the PRRSV replication in a naive
piglet during the bioassay experiment.
The results of the predicted protein sequence analyses are
summarized in Table 3 as translated amino acid sequences
compared to the parental PRRSV 16244B strain. No changes
were observed in isolates recovered at 7 dpi. However, at 84
and 150 dpi, changes were observed in all the samples analyzed. The average nonsynonymous/synonymous mutation ratios for individual genes at 84 and 150 dpi indicate that selective pressure for amino acid change is likely exerted in genes
coding for the major viral glycoproteins during establishment
of persistence (Table 4). In fact, ORF3, ORF4, and ORF5
were the more variable genes during persistence, while ORF2
changed only moderately (Tables 3 and 4). Nsp1␣ and ORF6
were substantially less variable than the glycoproteins, and the
ORF7 predicted protein remained unchanged during persistence (Table 4). Similar observations were reported for ORF2
to ORF7 of other arteriviruses (7). The high degree of conservation observed for N protein from persistent PRRSV isolates agrees with data reported for other arteriviruses (7). This
protein as well as the 5⬘ NCR and 3⬘ NCR have a potential role
in genome packaging during virion assembly or in the complex
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TABLE 4. Average nucleotide substitution rate in ORF2 to
ORF7 of PRRSV persistent isolates

Genome region

Nsp1␣
ORF2
ORF3
ORF4
ORF5
ORF6
ORF7

Ratio of nonsynonymous substitutions
per site/synonymous substitutions
per site at dpi:
84a

150b

1.330
0.800
1.146
1.964
2.515
0.090
0/0.001c

0/0.002c
0/0.001c
0.730
0.790
1.000
0.002/0d
0/0.001c

a

Averages of five animals (3-84b, 22-84b, 27-84b, 31-84b, and 32-84b).
Averages of two animals (3-150b and 31-150b).
All nucleotide changes were synonymous.
d
All nucleotide changes were nonsynomous.
b
c

transcription process (6); thus, structural restrictions are imposed on nucleotides in this region of PRRSV, as indicated by
our results.
Although antigenic variation of gp3 has been associated with
variation of PRRSV through serial passage in swine (9), the
mechanism of variant selection during persistence is not clear.
High glycosylation and variability of PRRSV gp3 suggest that
this protein is involved in virus-host cell interactions (9, 12).
Our data indicate that strong selective pressure is likely exerted on the PRRSV gp3 during establishment of and throughout persistence in the natural host. Regarding gp5, two out of
three changes observed were located in the ectodomain region
of the protein. Changes in the PRRSV gp5 ectodomain have
been associated with selection of a viral subpopulation through
quasispecies evolution during persistence (14). Although we
identified mutations in the ectodomain of the glycoprotein, we
did not observe the mutation at position 34 that appeared to be
the hallmark of the quasispecies identified by Rowland et al.
(14) during persistence. Ours and theirs are not necessarily
contrasting results, because Rowland et al. also reported that,
when they repeated the experiments using a different strain of
PRRSV, they again observed the emergence of a new subpopulation of PRRSV RNA, characterized by a mutation in a
different position of the ectodomain (14).
Recently, PRRSV M protein has been reported to be a
major target of cell-mediated immunity (3). The M protein is
a structural protein with three transmembrane domains, and
structural requirements likely restrict amino acid alteration in
the protein. Surprisingly, we identified two amino acid mutations in this protein (Table 3). Although we did not study the
cell-mediated response of the animals in these experiments
and very little is known in general about the topic, our results
could suggest that mutations in M protein determine a delay in
the process of viral clearance from the body.
The results of this study suggest that PRRSV persists
through a “smoldering” type of infection in which the virus
replicates at low levels over time. The virus eventually clears
the body and seems to do it in the majority of the animals by
150 dpi or shortly thereafter. High genetic stability was observed in both NCRs and in the nucleocapsid protein during
persistence. However, genes coding for the glycoproteins and
the M protein of PRRSV had mutations that could be associated with putative changes which may be involved in maintenance of persistence.
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